Flavonifractor Plautii or Its Metabolite Desaminotyrosine as Prophylactic Agents for Alleviating Myocardial...

Area of Science:

• Cardiovascular Science
• Microbiology
• Metabolomics

Background:

• Myocardial ischemia/reperfusion (I/R) injury causes significant cardiac damage and dysfunction.
• Gut microbiota metabolites are increasingly recognized for their role in cardiovascular health.
• Flavonifractor plautii (F. plautii) is a gut bacterium with potential therapeutic applications.

Purpose of the Study:

• To investigate the cardioprotective effects of F. plautii and its metabolite desaminotyrosine (DAT) against myocardial I/R injury.
• To elucidate the underlying mechanisms of DAT-mediated cardioprotection.

Main Methods:

• Prophylactic gavage of F. plautii in a mouse model of myocardial I/R injury.
• Administration of DAT and assessment of cardiac function and injury markers.
• Transcriptomic analysis to identify molecular pathways affected by DAT.
• Measurement of cardiomyocyte survival and inflammatory markers (IL-6).

Main Results:

• F. plautii administration attenuated myocardial I/R injury, improving cardiac function and reducing damage.
• DAT administration replicated the cardioprotective effects of F. plautii.
• DAT preserved cardiac tissue and reduced immune responses post-I/R injury.
• DAT enhanced cardiomyocyte survival by modulating the NADP+/NADPH ratio and suppressed macrophage pro-inflammatory activity, reducing IL-6 production.

Conclusions:

• F. plautii and its metabolite DAT demonstrate significant cardioprotective effects against myocardial I/R injury.
• DAT exerts pleiotropic effects, including promoting cardiomyocyte survival and reducing inflammation.
• F. plautii and DAT represent promising prophylactic therapeutic strategies for mitigating myocardial I/R injury.